Christopher R Flowers

Christopher R. Flowers is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on lymphoid neoplasia, hematological malignancies, and the tumor microenvironment, with particular emphasis on large B cell lymphoma archetypes and relapsed/refractory diffuse large B-cell lymphoma therapies. His recent work spans patient perspectives on lymphoma clinical trial enrollment, cytokine storms in CAR-T therapy, and the gut microbiome's role in response to idecabtagene vicleucel. He has also investigated ibrutinib and nivolumab combinations for CNS lymphomas and regulatory T cells for ALS, publishing in venues including Cancer Cell, JAMA Network Open, and NEJM Evidence.